Showing results (131-140 of 150) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|April 19, 2000
Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infectionA Cossarizza, G Stent, C Mussini, et al.
The International Journal of Artificial Organs|January 1, 1981
Kinetics of amino acids equilibration in the dialysate during CAPDN G De Santo, G Capodicasa, V A Di Leo, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|March 3, 2020
Resection of the irradiated esophagus: the impact of lymph node yield on survivalV R Esposito, B A Yerokun, M S Mulvihill, et al.
Transplantation Direct|May 1, 2018
Neurological Sequelae and Clinical Outcomes After Lung TransplantationPatrick J Smith, Gregory L Stonerock, Krista K Ingle, et al.
Infection|May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER CohortsC Torti, G Lapadula, A Antinori, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 30, 2001
Minimally invasive versus sternotomy approaches for mitral reconstruction: comparison of intermediate-term resultsE A Grossi, A LaPietra, G H Ribakove, et al.
The Journal of Clinical Endocrinology and Metabolism|August 15, 2015
Outcomes and Risk Factors for Complications of Laser Ablation for Thyroid Nodules: A Multicenter Study on 1531 PatientsC M Pacella, G Mauri, G Achille, et al.
AIDS Patient Care and Stds|February 5, 2008
Long-term psychometric outcomes of facial lipoatrophy therapy: forty-eight-week observational, nonrandomized studyG Orlando, G Guaraldi, D De Fazio, et al.
The Journal of Infectious Diseases|May 24, 2000
Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis studyC Mussini, P Pezzotti, A Govoni, et al.
Scientific Reports|December 27, 2022
Similar programmed death ligand 1 (PD-L1) expression profile in patients with mild COPD and lung cancerF Polverino, D Mirra, C X Yang, et al.
Pageof 15